Yasuhiko Nakamura Hiromi Sanai Ichiro Miwa
10.1177/2050313X18819599
SAGE Open Med Case Rep
2018 Dec 20;6:2050313X18819599.
endometrial adenocarcinoma etoposide recurrent tumor refractory tumor
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30788108/
Case Reports
PMC6372995
30788108
Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide
2018